OCI Reports Q3 Operating Loss of ₩6.6 Billion Amid Weak Market and One-Off Costs

Reporter Kim Jisun / approved : 2025-10-29 03:27:39
  • -
  • +
  • 인쇄

Photo courtesy of OCI

 

 

[Alpha Biz= Kim Jisun] SEOUL, October 28, 2025 — OCI Co., Ltd. reported consolidated revenue of ₩476.3 billion (US$343 million) and an operating loss of ₩6.6 billion (US$4.8 million) for the third quarter of 2025, according to a regulatory filing released Tuesday.


Revenue declined 19.1% year-on-year and 9.6% quarter-on-quarter, marking the company’s second consecutive quarterly loss.
Net loss for the quarter totaled ₩49.3 billion (US$35 million), compared with a net profit of ₩13.9 billion (US$10 million) in the same period last year.


OCI attributed the downturn to continued weakness in global market conditions and non-recurring expenses, including asset impairments related to its newly acquired subsidiary P&O Chemical.


P&O Chemical, which manufactures pitch materials for secondary batteries and hydrogen peroxide for semiconductors, was fully acquired by OCI in March 2025 after the company purchased POSCO Future M’s 51% stake in their former joint venture.


The third-quarter results included a ₩70.5 billion (US$50.7 million) impairment loss associated with P&O Chemical’s High Softening Point Pitch (HSPP) business, impacting profitability.


An OCI spokesperson explained:

“We recognized an impairment loss on the HSPP production facility during the quarter, which weighed heavily on earnings. However, with these one-off expenses now reflected, we expect an earnings rebound starting in the fourth quarter.”


The company added that synergies from integrating P&O Chemical and fixed-cost reductions are expected to improve operational efficiency in the coming quarters.

 

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

주요기사

IBK Investment & Securities Says Solus Advanced Materials’ Turnaround Delayed to Late 2026 Amid Weak EV Demand2025.10.29
Daehan Steel and Investors File Lawsuit Against Mirae Asset Global Investments Over Alleged Unjust Enrichment2025.10.29
Prosecutors Indict CEO of Seoyoung Holdings for Illegal Loans and Embezzlement Involving NH NongHyup Bank Executive2025.10.29
Shinsegae International Transfers ‘JAJU’ Lifestyle Division to Shinsegae Casa for ₩94 Billion2025.10.29
Kwangdong Pharmaceutical Withdraws Exchangeable Bond Issuance After Financial Regulator Flags “Misleading Disclosure”2025.10.29
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사